z-logo
Premium
Signaling mechanisms involved in protease‐activated receptor‐1 mediated nitric oxide production.
Author(s) -
Watts Vabren L,
Motley Evangeline D
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.23.1_supplement.816.8
Subject(s) - enos , phosphorylation , nitric oxide , thrombin , microbiology and biotechnology , nitric oxide synthase , receptor , chemistry , nitric oxide synthase type iii , signal transduction , agonist , biochemistry , medicine , pharmacology , biology , endocrinology , platelet
Protease‐activated receptors (PARs) are G protein‐coupled receptors that are known to regulate endothelial nitric oxide synthase (eNOS) activity by phosphorylating the enzyme at various sites. Phosphorylation of eNOS‐Thr495 negatively regulates eNOS activity by causing a decrease in nitric oxide (NO) production. Currently, the mechanisms for eNOS‐Thr495 phosphorylation by PAR agonists are unknown. In this study, we used a specific synthetic PAR‐1 activating peptide, TFLLR, and thrombin to assess the role of PAR‐1 involvement in NO production in endothelial cells. Both agonists phosphorylated Thr495 in a time‐ and concentration‐dependent manner. Also, cells pretreated with a PAR‐1 inhibitor, showed a significant decrease in thrombin and TFLLR‐induced phosphorylation of eNOS Thr495. Rho and Rho‐Kinase inhibitors also caused a significant decrease in PAR‐1‐induced Thr495 phosphorylation. In addition, we observed that both PAR‐1 agonists caused a significant decrease in nitrite production, whereas inhibition of PAR‐1, Rho, and ROCK caused a significant increase in PAR‐1 agonist‐mediated nitrite production. This suggests that PAR‐1 induces phosphorylation of eNOS‐Thr495 and inhibition of NO production via a Rho/ROCK dependent pathway. These findings will contribute to understanding the signaling pathways that regulate eNOS‐induced nitric oxide production. NIH‐NCRR 2G12RR03032.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here